ArticleEuropean radiology2026
Comparative evaluation of generative AI models for chest radiograph report generation in the emergency department.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo benchmark medical image-specific vision-language models (VLMs) against real-world radiologist-written reports, focusing on diagnostic quality, clinical acceptability, hallucinations, and language clarity. MATERIALS AND
methodsThis retrospective study included adult patients who presented to the emergency department of a tertiary center between January 2022 and April 2025 and underwent same-day chest radiograph (CXR) and CT for febrile or respiratory symptoms. Reports from five VLMs (AIRead, Lingshu, MAIRA-2, MedGemma, and MedVersa) and radiologist-written reports were randomly presented and blindly evaluated by three thoracic radiologists using four criteria: RADPEER, clinical acceptability, hallucination, and language clarity. Comparative performance was assessed using generalized linear mixed models, with radiologist-written reports treated as the reference. Finding-level analyses were also performed with CT as a reference.
resultsA total of 478 patients (median age, 67 years [interquartile range, 50-78]; 282 males [59.0%]) were included. AIRead demonstrated the lowest RADPEER 3b rate (5.3% [76/1434] vs radiologists 13.9% [200/1434]; p < 0.001) and the highest clinical acceptability (84.5% [1212/1434] vs radiologists 74.3% [1065/1434]; p < 0.001), with hallucination rates comparable to radiologists (0.3% [4/1425]) vs 0.1% [1/1425]; p = 0.21). Other VLMs showed higher disagreement (16.8-43.0%; p < 0.05), lower acceptability (41.1-71.4%; p < 0.05), and more frequent hallucinations (5.4-17.4%; p < 0.05). Language clarity was higher for several VLMs (AIRead, Lingshu, and MedVersa) than for radiologist-written reports (82.9-88.4% [1189-1268/1434] vs 78.1% [1120/1434]; p < 0.05). Finding-level analyses showed substantial variability in sensitivity across VLMs for common thoracic findings.
conclusionMedical VLMs for CXR report generation exhibited variable performance in report quality and diagnostic measures. KEY POINTS: Question How do medical VLMs perform compared with radiologist-written reports regarding diagnostic quality, clinical acceptability, hallucinations, and language clarity for CXRs? Findings One non-open-source VLM achieved the lowest RADPEER 3b rate and highest acceptability with radiologist-level hallucinations, whereas other models showed inferior performance. Clinical relevance VLMs may support automated preliminary CXR reporting and serve as adjunct tools to enhance workflow efficiency and consistency. Although performance varied widely, carefully developed models approached radiologist-level quality, supporting continued refinement and targeted clinical integration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.